Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAN2 study of mycophenolate mofetil in antiretroviral-naive chronic HIV-1 infection
NL-OMON21098Active, not recruiting
- Sponsor
- National AIDS Therapy Evaluation Center
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mycophenolate mofetil in Human immunodeficiency virus infection type 1 (2 arms), sponsored by National AIDS Therapy Evaluation Center. Primary endpoints: Change in CD4+ T-cell count and Change in PBMC activation markers. Started Mar 2005; status: active, not recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON21098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21098.